Niagen Bioscience, Inc. Common Stock (NASDAQ: NAGE) last traded at $3.21, up 1.90% on the session. The quote above updates while this page is open; the figures below are drawn from Niagen Bioscience, Inc. Common Stock’s own filings and are restated only when a new one is published.
Niagen Bioscience, Inc. Common Stock trades on NASDAQ under the ticker NAGE. Its market capitalisation is $253.99 million.
Valuation measures for Niagen Bioscience, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $253.99M |
|---|---|
| Enterprise value | $213.96M |
| P/E ratio | 17.83 |
| Price / sales | 1.97 |
| Price / book | 3.08 |
| Beta | 1.24 |
Trailing-twelve-month figures tagged in Niagen Bioscience, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $129.08M |
|---|---|
| Net income (TTM) | $15.99M |
| EPS (TTM) | $0.180 |
| Gross margin | 64.24% |
| Operating margin | 8.21% |
| Return on equity | 19.38% |
| Cash | $64.10M |
Range and volume for NAGE over the past 52 weeks.
| 52-week high | $10.52 |
|---|---|
| 52-week low | $2.87 |
| Volume | 359.9K |
| Average volume | 746.3K |
| Previous close | $3.15 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.